Induction of acute inflammatory reactions in lung following intrapulmonary instillation of preformed chemotactic peptides and purified complement components.
D000208:Acute Disease; D000818:Animals; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D003182:Complement C5; D006224:Cricetinae; D004305:Dose-Response Relationship, Drug; D004306:Dose-Response Relationship, Immunologic; D006469:Hemoptysis / Q000209:etiology / Q000473:pathology; D006801:Humans; D007442:Intubation, Intratracheal; D008168:Lung / Q000473:pathology; D008297:Male; D008715:Methionine / Q000031:analogs & derivatives*; D009239:N-Formylmethionine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D009842:Oligopeptides / Q000008:administration & dosage / Q000009:adverse effects*; D011014:Pneumonia / Q000209:etiology* / Q000473:pathology; D011654:Pulmonary Edema / Q000209:etiology / Q000473:pathology; D011817:Rabbits; D012709:Serum Albumin / Q000008:administration & dosage
D003182:Complement C5; D009842:Oligopeptides; D012709:Serum Albumin; D009239:N-Formylmethionine; D008715:Methionine